A new oral isocitrate dehydrogenase-2 inhibitor——enasidenib

HAO Bo-jun, LI Yong-jing*

Clinical Medication Journal ›› 2017, Vol. 15 ›› Issue (10) : 6-11.

PDF(603 KB)
Welcome to visit Clinical Medication Journal!
PDF(603 KB)
Clinical Medication Journal ›› 2017, Vol. 15 ›› Issue (10) : 6-11. DOI: 10.3969/j.issn.1672-3384.2017.10.002

A new oral isocitrate dehydrogenase-2 inhibitor——enasidenib

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2017, 15(10): 6-11 https://doi.org/10.3969/j.issn.1672-3384.2017.10.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(603 KB)

Accesses

Citation

Detail
Sections
Recommended
Copyright © Clinical Medication Journal, All Rights Reserved.
Tel: 010-64178704转301/302/305/306　
E-mail：zazhi@vip.sina.com
Powered by Beijing Magtech Co. Ltd.

/

〈 〉